Joint Formulary & PAD

Olanzapine - Eating disorders

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red
Formulations :
  • Oro-dispersible tablets
  • Tablets
Associated Icons :
Off Label
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Olanzapine
Indication :
Eating disorders
Group Name :
Keywords :
anorexia nervosa
Brand Names Include :
Important Information :

For the reduction of distress at mealtimes in anorexia nervosa.

Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Drugs

Below are listed other drugs that are used to treat Eating disorders.

  • No records returned.

Committee Recommendations (0)

  • No records returned.